GenomeNet

Database: UniProt
Entry: Q9NP60
LinkDB: Q9NP60
Original site: Q9NP60 
ID   IRPL2_HUMAN             Reviewed;         686 AA.
AC   Q9NP60; Q2M3U3; Q9NZN0;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   04-NOV-2026, entry version 183.
DE   RecName: Full=X-linked interleukin-1 receptor accessory protein-like 2;
DE            Short=IL-1 receptor accessory protein-like 2;
DE            Short=IL-1-RAPL-2;
DE            Short=IL-1RAPL-2;
DE            Short=IL1RAPL-2;
DE            EC=3.2.2.6 {ECO:0000255|PROSITE-ProRule:PRU00204};
DE   AltName: Full=IL1RAPL-2-related protein;
DE   AltName: Full=Interleukin-1 receptor 9;
DE            Short=IL-1R-9;
DE            Short=IL-1R9;
DE   AltName: Full=Three immunoglobulin domain-containing IL-1 receptor-related 1;
DE            Short=TIGIRR-1;
DE   Flags: Precursor;
GN   Name=IL1RAPL2; Synonyms=IL1R9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=11031108; DOI=10.1006/geno.2000.6328;
RA   Sana T.R., Debets R., Timans J.C., Bazan J.F., Kastelein R.A.;
RT   "Computational identification, cloning, and characterization of IL-1R9, a
RT   novel interleukin-1 receptor-like gene encoded over an unusually large
RT   interval of human chromosome Xq22.2-q22.3.";
RL   Genomics 69:252-262(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=10882729; DOI=10.1074/jbc.m004077200;
RA   Born T.L., Smith D.E., Garka K.E., Renshaw B.R., Bertles J.S., Sims J.E.;
RT   "Identification and characterization of two members of a novel class of the
RT   interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-
RT   related proteins based on signaling.";
RL   J. Biol. Chem. 275:29946-29954(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Grabowski M., Lorenz B., Hubel R., Strom T.M.;
RT   "A gene (IL1RAPL-2) with 61% identity to IL1RAPL maps to Xq22.2.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11587848; DOI=10.1016/s0378-1119(01)00659-x;
RA   Ferrante M.I., Ghiani M., Bulfone A., Franco B.;
RT   "IL1RAPL2 maps to Xq22 and is specifically expressed in the central nervous
RT   system.";
RL   Gene 275:217-221(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 29-686.
RX   PubMed=10757639; DOI=10.1038/sj.ejhg.5200415;
RA   Jin H., Gardner R.J., Viswesvaraiah R., Muntoni F., Roberts R.G.;
RT   "Two novel members of the interleukin-1 receptor gene family, one deleted
RT   in Xp22.3-Xp21.3 mental retardation.";
RL   Eur. J. Hum. Genet. 8:87-94(2000).
RN   [9]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-606.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NAD(+) + H2O = ADP-D-ribose + nicotinamide + H(+);
CC         Xref=Rhea:RHEA:16301, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17154, ChEBI:CHEBI:57540, ChEBI:CHEBI:57967; EC=3.2.2.6;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00204};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16302;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00204};
CC   -!- INTERACTION:
CC       Q9NP60; P22607: FGFR3; NbExp=3; IntAct=EBI-20865879, EBI-348399;
CC       Q9NP60; P23468: PTPRD; NbExp=2; IntAct=EBI-20865879, EBI-2682990;
CC       Q9NP60; Q13332: PTPRS; NbExp=3; IntAct=EBI-20865879, EBI-711536;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- TISSUE SPECIFICITY: Detected at low levels in fetal and adult brain, in
CC       particular in the frontal lobe, temporal lobe and cerebellum. Detected
CC       at very low levels in skin, liver, fetal ovary and in placenta.
CC       {ECO:0000269|PubMed:10882729, ECO:0000269|PubMed:11031108,
CC       ECO:0000269|PubMed:11587848}.
CC   -!- DOMAIN: The TIR domain mediates NAD(+) hydrolase (NADase) activity.
CC       Self-association of TIR domains is required for NADase activity.
CC       {ECO:0000255|PROSITE-ProRule:PRU00204}.
CC   -!- SIMILARITY: Belongs to the interleukin-1 receptor family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF212016; AAF61307.1; -; mRNA.
DR   EMBL; AF284436; AAG21370.1; -; mRNA.
DR   EMBL; AJ272208; CAB86868.1; -; mRNA.
DR   EMBL; AJ290436; CAB89867.1; -; mRNA.
DR   EMBL; AK290196; BAF82885.1; -; mRNA.
DR   EMBL; AL050401; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z68328; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z68330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z68908; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z69721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z74477; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z74619; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z81144; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF181285; AAF59412.1; -; mRNA.
DR   EMBL; BC104784; AAI04785.1; -; mRNA.
DR   EMBL; BC104786; AAI04787.1; -; mRNA.
DR   CCDS; CCDS14517.1; -.
DR   RefSeq; NP_059112.1; NM_017416.2.
DR   PDB; 7FD3; X-ray; 2.99 A; A=400-560.
DR   PDB; 7SZL; X-ray; 2.30 A; A=400-559.
DR   AlphaFoldDB; Q9NP60; -.
DR   SMR; Q9NP60; -.
DR   BioGRID; 117663; 5.
DR   FunCoup; Q9NP60; 48.
DR   IntAct; Q9NP60; 6.
DR   STRING; 9606.ENSP00000361663; -.
DR   GlyCosmos; Q9NP60; 5 sites, No reported glycans.
DR   GlyGen; Q9NP60; 5 sites.
DR   iPTMnet; Q9NP60; -.
DR   PhosphoSitePlus; Q9NP60; -.
DR   BioMuta; IL1RAPL2; -.
DR   DMDM; 34222651; -.
DR   PaxDb; 9606-ENSP00000361663; -.
DR   PeptideAtlas; Q9NP60; -.
DR   ProteomicsDB; 81891; -.
DR   Antibodypedia; 35255; 297 antibodies from 33 providers.
DR   DNASU; 26280; -.
DR   Ensembl; ENST00000372582.6; ENSP00000361663.1; ENSG00000189108.14.
DR   GeneID; 26280; -.
DR   KEGG; hsa:26280; -.
DR   MANE-Select; ENST00000372582.6; ENSP00000361663.1; NM_017416.2; NP_059112.1.
DR   UCSC; uc004elz.1; human.
DR   AGR; HGNC:5997; -.
DR   ClinPGx; PA29813; -.
DR   CTD; 26280; -.
DR   DisGeNET; 26280; -.
DR   GeneCards; IL1RAPL2; -.
DR   HGNC; HGNC:5997; IL1RAPL2.
DR   HPA; ENSG00000189108; Tissue enhanced (adrenal).
DR   MIM; 300277; gene.
DR   OpenTargets; ENSG00000189108; -.
DR   VEuPathDB; HostDB:ENSG00000189108; -.
DR   eggNOG; KOG3971; Eukaryota.
DR   GeneTree; ENSGT01150000286976; -.
DR   HOGENOM; CLU_025552_0_1_1; -.
DR   InParanoid; Q9NP60; -.
DR   OMA; ACDGVKY; -.
DR   OrthoDB; 9925886at2759; -.
DR   PAN-GO; Q9NP60; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9NP60; -.
DR   PathwayCommons; Q9NP60; -.
DR   Reactome; R-HSA-388844; Receptor-type tyrosine-protein phosphatases.
DR   SignaLink; Q9NP60; -.
DR   SIGNOR; Q9NP60; -.
DR   Agora; ENSG00000189108; -.
DR   BioGRID-ORCS; 26280; 17 hits in 764 CRISPR screens.
DR   ChiTaRS; IL1RAPL2; human.
DR   GeneWiki; IL1RAPL2; -.
DR   GenomeRNAi; 26280; -.
DR   Pharos; Q9NP60; Tbio.
DR   PRO; PR:Q9NP60; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q9NP60; protein.
DR   Bgee; ENSG00000189108; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 90 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0004908; F:interleukin-1 receptor activity; TAS:ProtInc.
DR   GO; GO:0004910; F:interleukin-1, type II, blocking receptor activity; IEA:InterPro.
DR   GO; GO:0061809; F:NAD+ nucleosidase activity, cyclic ADP-ribose generating; IEA:UniProtKB-EC.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:1905606; P:regulation of presynapse assembly; IDA:SynGO.
DR   CDD; cd05757; Ig2_IL1R-like; 1.
DR   FunFam; 2.60.40.10:FF:000188; Interleukin-1 receptor accessory protein-like 1; 1.
DR   FunFam; 2.60.40.10:FF:000284; interleukin-1 receptor accessory protein-like 1; 1.
DR   FunFam; 2.60.40.10:FF:000220; X-linked interleukin-1 receptor accessory protein-like 1; 1.
DR   FunFam; 3.40.50.10140:FF:000004; X-linked interleukin-1 receptor accessory protein-like 1; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 3.
DR   Gene3D; 3.40.50.10140; Toll/interleukin-1 receptor homology (TIR) domain; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR015621; IL-1_rcpt_fam.
DR   InterPro; IPR004077; IL-1_rcpt_II-typ.
DR   InterPro; IPR000157; TIR_dom.
DR   InterPro; IPR035897; Toll_tir_struct_dom_sf.
DR   PANTHER; PTHR11890; INTERLEUKIN-1 RECEPTOR FAMILY MEMBER; 1.
DR   PANTHER; PTHR11890:SF10; X-LINKED INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN-LIKE 2; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF13895; Ig_2; 1.
DR   Pfam; PF01582; TIR; 1.
DR   PRINTS; PR01539; INTRLEUKN1R2.
DR   PRINTS; PR01537; INTRLKN1R1F.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00255; TIR; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 3.
DR   SUPFAM; SSF52200; Toll/Interleukin receptor TIR domain; 1.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS50104; TIR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; Glycoprotein; Hydrolase;
KW   Immunoglobulin domain; Membrane; NAD; Proteomics identification; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000255"
FT   CHAIN           17..686
FT                   /note="X-linked interleukin-1 receptor accessory protein-
FT                   like 2"
FT                   /id="PRO_0000015459"
FT   TOPO_DOM        17..354
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        355..375
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        376..686
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          18..132
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          141..232
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          239..347
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          400..556
FT                   /note="TIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   ACT_SITE        488
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   CARBOHYD        63
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        120
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        136
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        211
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        328
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        53..116
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        162..214
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        265..331
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VARIANT         606
FT                   /note="F -> L (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036592"
FT   STRAND          402..407
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   HELIX           421..425
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   HELIX           426..430
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   HELIX           434..438
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   HELIX           446..449
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   HELIX           456..465
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   STRAND          467..474
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   HELIX           476..481
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   TURN            482..484
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   HELIX           485..489
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   HELIX           491..499
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   STRAND          501..508
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   HELIX           515..526
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   STRAND          529..535
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   HELIX           539..542
FT                   /evidence="ECO:0007829|PDB:7SZL"
FT   STRAND          543..545
FT                   /evidence="ECO:0007829|PDB:7FD3"
FT   HELIX           547..555
FT                   /evidence="ECO:0007829|PDB:7SZL"
SQ   SEQUENCE   686 AA;  78670 MW;  E400F7ECD186957C CRC64;
     MKPPFLLALV VCSVVSTNLK MVSKRNSVDG CIDWSVDLKT YMALAGEPVR VKCALFYSYI
     RTNYSTAQST GLRLMWYKNK GDLEEPIIFS EVRMSKEEDS IWFHSAEAQD SGFYTCVLRN
     STYCMKVSMS LTVAENESGL CYNSRIRYLE KSEVTKRKEI SCPDMDDFKK SDQEPDVVWY
     KECKPKMWRS IIIQKGNALL IQEVQEEDGG NYTCELKYEG KLVRRTTELK VTALLTDKPP
     KPLFPMENQP SVIDVQLGKP LNIPCKAFFG FSGESGPMIY WMKGEKFIEE LAGHIREGEI
     RLLKEHLGEK EVELALIFDS VVEADLANYT CHVENRNGRK HASVLLRKKD LIYKIELAGG
     LGAIFLLLVL LVVIYKCYNI ELMLFYRQHF GADETNDDNK EYDAYLSYTK VDQDTLDCDN
     PEEEQFALEV LPDVLEKHYG YKLFIPERDL IPSGTYMEDL TRYVEQSRRL IIVLTPDYIL
     RRGWSIFELE SRLHNMLVSG EIKVILIECT ELKGKVNCQE VESLKRSIKL LSLIKWKGSK
     SSKLNSKFWK HLVYEMPIKK KEMLPRCHVL DSAEQGLFGE LQPIPSIAMT STSATLVSSQ
     ADLPEFHPSD SMQIRHCCRG YKHEIPATTL PVPSLGNHHT YCNLPLTLLN GQLPLNNTLK
     DTQEFHRNSS LLPLSSKELS FTSDIW
//
DBGET integrated database retrieval system